AI-CVD vs Merlin.net

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung AI

Merlin.net

by Abbott (formerly St. Jude Medical)

AI Verdict

AI-CVD is an AI-powered imaging platform for opportunistic screening of cardiovascular and multisystem diseases using existing CT scans, focusing on early detection. Merlin.net is a remote monitoring platform designed for clinicians to manage data from patients with Abbott implanted cardiac devices, enabling remote follow-up and device performance monitoring. While both serve cardiology, AI-CVD targets early disease detection via imaging analysis, whereas Merlin.net focuses on ongoing patient management for those with implanted devices.

Choose AI-CVD if…

Choose AI-CVD if your primary objective is to opportunistically screen for hidden cardiovascular and multisystem disease risks using existing CT scans. This platform is ideal for leveraging routine imaging data to identify conditions like coronary artery calcium and cardiac chamber abnormalities without requiring additional patient visits or radiation exposure.

View AI-CVD →

Choose Merlin.net if…

Choose Merlin.net if you require a robust remote monitoring platform specifically designed for managing patients with Abbott-implanted cardiac devices. This tool is best suited for clinicians who need to streamline remote follow-up, monitor device performance, receive timely alerts for patient events, and integrate cardiac device data seamlessly into their EHR system.

View Merlin.net →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	Merlin.net
Deployment	Unknown	Web-based
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Merlin.net

Merlin.net offers a comprehensive web-based platform with features like EHR integration, alerts, and communication tools, suggesting a highly integrated and user-friendly experience for managing remote patient data. While AI-CVD focuses on seamless integration into existing radiology workflows, Merlin.net's detailed feature set for clinician interaction and data management points to a more developed and integrated user experience for its specific purpose.

Clinical Value

AI-CVD

Both tools are FDA-cleared and offer significant clinical value in their respective domains. AI-CVD provides opportunistic screening for a broad range of cardiovascular and multisystem diseases from existing CT scans, enabling early detection of hidden health risks. Merlin.net offers critical remote monitoring and management for patients with implanted cardiac devices, optimizing ongoing care; however, AI-CVD's potential to identify previously undiagnosed conditions across a wider population through opportunistic screening represents a distinct and impactful clinical value.

Pricing & Value

Tie

Both tools require contacting the vendor directly for pricing information. Without specific pricing details or publicly available data on their respective return on investment, it is impossible to definitively determine which tool offers better value.

Enterprise Readiness

Merlin.net

Merlin.net, developed by Abbott, explicitly states HIPAA compliance, BAA availability, FDA clearance, and seamless EHR integration via HL7 standards. AI-CVD also has FDA clearance and cloud deployment, but its BAA and HIPAA compliance are listed as 'likely, contact vendor.' Abbott's established presence and explicit compliance statements make Merlin.net demonstrably more enterprise-ready.

Innovation

AI-CVD

AI-CVD leverages AI for opportunistic screening of multiple cardiovascular and multisystem diseases using *existing* CT scans, without requiring additional imaging or workflow disruption. This approach to early, passive detection of hidden health risks is highly innovative. Merlin.net provides a comprehensive remote monitoring platform for implanted cardiac devices with advanced features, but the core concept of remote monitoring for these devices is more established.

Support & Docs

Tie

The provided structured facts do not contain specific details regarding support or documentation for either tool. While Abbott's size suggests robust support for Merlin.net, and HeartLung Corporation would undoubtedly offer some level of support for AI-CVD, there is insufficient explicit information to make a definitive comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	Merlin.net
Name	AI-CVD	Merlin.net
Company	HeartLung Corporation	Abbott
Primary Function	AI-powered quantitative imaging platform for opportunistic screening for cardiovascular and multisystem diseases using existing CT scans.	Web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices.
Categories	Cardiology AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Feature Example 1	Opportunistic screening from existing chest and abdominal CT scans	Remote monitoring of Abbott implanted cardiac devices
Key Feature Example 2	Coronary Artery Calcium (CAC) scoring	EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards)

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Merlin.net.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application difference between AI-CVD and Merlin.net?

AI-CVD is an AI-powered quantitative imaging platform designed for opportunistic screening of cardiovascular and multisystem diseases using existing CT scans, focusing on early detection of hidden health risks. Merlin.net is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up and device performance monitoring.

What kind of patient data do these tools utilize?

AI-CVD analyzes existing chest and abdominal CT scans to provide automated anatomical and density-based measurements. Merlin.net collects and manages data directly from Abbott implanted cardiac devices for remote patient care.

Can both tools assist in the early detection of cardiovascular disease in asymptomatic patients?

AI-CVD is specifically designed for opportunistic screening and early disease detection from existing CT scans, identifying hidden health risks. Merlin.net focuses on the ongoing management and monitoring of patients who already have implanted cardiac devices, rather than initial asymptomatic screening.

How do these tools integrate into a physician's existing workflow?

AI-CVD integrates by utilizing existing CT scans without requiring additional imaging, radiation, contrast, or workflow disruption. Merlin.net offers a web-based interface for clinicians, featuring EHRDirectu2122 data transfer for seamless EHR integration and SmartScheduleu2122 for follow-up coordination.

What specific cardiovascular measurements or insights does each tool provide?

AI-CVD provides automated measurements such as Coronary Artery Calcium (CAC) scoring, aortic wall, aortic valve, and mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry. Merlin.net offers data management and review of cardiac information from implanted devices, including DirectTrendu2122 viewer for dynamic device and clinical trends.

Are these tools limited to cardiology, or do they have broader applicability?

While both are relevant to cardiology, AI-CVD performs opportunistic screening for cardiovascular and *multisystem diseases* using CT scans, suggesting a broader scope. Merlin.net is specifically tailored for managing patients with *implanted cardiac devices*, primarily within the cardiology specialty.